By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cerus Corporation 

2411 Stanwell Drive

Concord  California  94520   U.S.A.
Phone: 925-288-6000 Fax: 925-288-6001


Medical Device



Company News
Cerus (CERS) Receives CE Mark Approval For The Contour Neurovascular System For The Treatment Of Intra-Cranial Aneurysms 7/7/2017 6:36:11 AM
Cerus (CERS) Release: INTERCEPT Blood System Highlighted At The International Society Of Blood Transfusion (ISBT) 6/21/2017 8:16:16 AM
Cerus (CERS) Provides Update On U.S. Platelet Additive Solution (PAS) Supply 6/7/2017 7:07:21 AM
Cerus (CERS) Provides U.S. Business Update 5/23/2017 9:47:07 AM
First Patient Transfused In Cerus (CERS)’ Phase III RedeS Study Evaluating Safety And Efficacy Of The INTERCEPT Red Blood Cell System 5/15/2017 8:34:08 AM
Cerus (CERS) Announces Exercise Of Additional BARDA Contract Options Totaling $46.6 Million To Support INTERCEPT Red Blood Cell System Development 5/9/2017 9:19:52 AM
Cerus (CERS) Reports First Quarter 2017 Results 5/4/2017 7:13:53 AM
Cerus (CERS) To Release First Quarter 2017 Results On May 3, 2017 4/19/2017 8:31:38 AM
Cerus (CERS) Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) 4/6/2017 8:04:44 AM
Cerus (CERS) Reports Fourth Quarter And Year End 2016 Results 3/8/2017 6:36:34 AM